Search results for

James Nurton, Nice

The European Commission has published controversial proposals to amend the Community Trade Mark Directive.

Recent developments in procedural rules for appeals from trade mark opposition hearings have highlighted the pitfalls of failing to be fully prepared at first instance, warns Jill Delaney

The difficulty of managing patent litigation is magnified with increasing numbers of alleged infringers and actions filed across the United States. Errol Taylor and Joshua Rothman describe the benefits that consolidating these actions can confer on corporations engaged in such complex litigation

Despite economic upheavals across Latin America, new governments and coming elections bring a promise of change - and improvement. Sam Mamudi reports

In part three of the World IP Survey, MIP reveals the leading patent firms from Argentina to Thailand, and specialists from the leading firms discuss current trends

Poland has recently adopted provisions concerning the legal protection of biotechnological inventions. This has been implemented by revision of the Industrial Property Law so as to adjust it to the provisions of Directive 98/44/EC of the European Parliament and of the Council of July 6 1998. The respective revision of the Industrial Property Law became effective as from October 18 2002.

Today, the vast majority of national patents pending in the European countries have evolved from patents granted by the European Patent Office. Even if the validity of such a patent has been confirmed in opposition proceedings before the European Patent Office, it can still be attacked in nullity proceedings before the national patent authorities. In national invalidation proceedings, any differences between the European Patent Office and the national authorities with respect to the interpretation of the basic standards for patentability might turn into a trap for the patent owner.

Restrictions on investment agreements and IP rights came under scrutiny in a recently decided case heard in the UK.

As the doctrine of equivalents comes under increased scrutiny, the three major patent markets are notable for their similarities more than their differences. Hugh Dunlop examines how jurisprudence in the US, Japan and Europe has matured, and discusses the options for harmonization